Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
European Journal of Haematology|March 1, 1995
Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic proceduresM von Eiff, M Zühlsdorf, N Roos, et al.
Annals of Hematology|March 1, 1995
Pulmonary fungal infections in patients with hematological malignancies--diagnostic approachesM von Eiff, M Zühlsdorf, N Roos, et al.
Blut|April 1, 1990
Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignanciesM von Eiff, M Essink, N Roos, et al.
Thrombosis and Haemostasis|December 18, 1987
Selective staining of platelet glycoproteins using two-dimensional O'Farrell gel electrophoresis and avidin-biotin-conjugated lectinsB Kehrel, R Kokott, L Balleisen, et al.
European Heart Journal|September 1, 1992
Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trialH Ostermann, U Schmitz-Huebner, J Windeler, et al.
Thrombosis and Haemostasis|October 30, 1985
Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractionsL Balleisen, G Assmann, J Bailey, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1995
Pulmonary aspergillosis: early diagnosis improves survivalM von Eiff, N Roos, R Schulten, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1994
Detection of atrial fusion systole in patients with dual chamber pacemakers by 24-hour esophagus ECGW Grille, T Holst, C Laessing, et al.
Anticancer Research|September 1, 1986
Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatinP Preusser, H Wilke, W Achterrath, et al.
Behring Institute Mitteilungen|August 1, 1988
Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early deathT Büchner, W Hiddemann, M Zühlsdorf, et al.
Pageof 22